Compounds > aica ribonucleotide

aica ribonucleotide and Heart Failure

aica ribonucleotide has been researched along with Heart Failure in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	5 (83.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du, B; Gao, L; Huang, Z; Kong, L; Li, Y; Liang, C; Liu, Y; Shi, H; Tian, X; Wang, Z; Wu, L; Yao, R; Zhang, D; Zhang, Y	1
Dyck, JR; Kim, TT	1
Sun, A; Wang, P; Xu, L	1
Asakura, M; Asanuma, H; Fujita, M; Ito, S; Kim, J; Kitakaze, M; Komamura, K; Minamino, T; Mochizuki, N; Ogai, A; Sanada, S; Sasaki, H; Sugimachi, M; Takahama, H; Takashima, S; Wakeno, M	1
McGaffin, KR; McTiernan, CF; O'Doherty, RM; O'Donnell, CP; Romano, LC; Witham, WG; Yester, KA	1
Li, L; Tao, HL; Wang, XF; Zhang, JY; Zhang, L; Zhao, XY	1

Reviews

2 review(s) available for aica ribonucleotide and Heart Failure

Article	Year
Is AMPK the savior of the failing heart? Trends in endocrinology and metabolism: TEM, 2015, Volume: 26, Issue:1 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Energy Metabolism; Heart; Heart Failure; Humans; Metformin; Myocardium; Ribonucleotides	2015
Energy Remodeling, Mitochondrial Disorder and Heart Failure. Current pharmaceutical design, 2016, Volume: 22, Issue:31 Topics: Aminoimidazole Carboxamide; Animals; Energy Metabolism; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mitochondrial Diseases; Ribonucleotides; Thiazolidinediones; Trimetazidine	2016

Other Studies

4 other study(ies) available for aica ribonucleotide and Heart Failure

Article	Year
Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling. Experimental cell research, 2018, 09-01, Volume: 370, Issue:1 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Fructose-Bisphosphate Aldolase; Heart; Heart Failure; Male; Mice; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Ribonucleotides; Signal Transduction; Up-Regulation	2018
Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation, 2009, May-19, Volume: 119, Issue:19 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Cells, Cultured; Disease Progression; Dogs; Drug Evaluation, Preclinical; Fibrosis; Gene Expression Regulation; Heart Failure; Insulin Resistance; Metformin; Myocytes, Cardiac; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Ribonucleotides; Transforming Growth Factor beta1; Ultrasonography; Ventricular Dysfunction, Left	2009
Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice. Cardiovascular research, 2011, Jan-01, Volume: 89, Issue:1 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Enzyme Activation; Glycolysis; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Cardiovascular; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Ribonucleotides; Signal Transduction; STAT3 Transcription Factor; Tamoxifen	2011
Metformin improves cardiac function in rats via activation of AMP-activated protein kinase. Clinical and experimental pharmacology & physiology, 2011, Volume: 38, Issue:2 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Echocardiography; Heart Failure; Hypoglycemic Agents; Insulin; Male; Metformin; Myocardium; Natriuretic Peptide, Brain; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Wistar; Ribonucleotides; Ventricular Function, Left; Ventricular Remodeling	2011